[1] World Health Organization. Polio vaccines: WHO position paper – June 2022. Wkly Epidemiol Rec 2022;97(25):277-300. https://www.who.int/publications/i/item/WHO-WER9725-277-300.
[2] Zhang XL, Wang KA. Lecture three: the poliomyelitis surveillance system in China. Disease Surveillance, 1995, 10(3): 95-96. https://kns.cnki.net/kcms2/article/abstract?v=IILC1c-FiAG8liQU4zhuXi0lxC9FzYgUbPdgnKiMSeXar89s9g32HZOgVqvGlvWJhGJYqCvcEPUZyJyV7qJDrv0CMYf_hmCNRtp2BmHQ14MStoUIwQ2GX33tUPbLjRh5hAKkW-IP7qQ=&uniplatform=NZKPT&language=CHS. (In Chinese
[3] Liu M, Yang BP. Implementation in 1992 in the national Plan of Action for Polio Eradication 1995. Disease Surveillance, 1993, 8(3): 63-66. DOI: 10.3784/j.issn.1003-9961.1993.3.63. (In Chinese
[4] Zhang YX, Wen N, Yu WZ, Luo HM. Establishment and application of the acute flaccid paralysis surveillance information reporting and management system in China. Chin J Vac Immun 2016;22(3):333 − 8,326. https://doi.org/10.19914/j.cjvi.2016.03.022CrossRef
[5] Yu WZ, Wang HB, Fan CX, Luo HM, Li L, Wen N. Study on timeliness of critical points of acute flaccid paralysis cases surveillance system in China from 1999 to 2011. Chin J Vac Immun 2013;19(1):11 − 6,30. https://doi.org/10.19914/j.cjvi.2013.01.003CrossRef
[6] Fan CX, Yang H, Wen N, Zhu SL, Su QR, Ma C, et al. Surveillance of acute flaccid paralysis cases in China, 2016. Chinese Journal of Vaccines and Immunization 2018;24(2):160 − 4. https://doi.org/10.19914/j.cjvi.2018.02.009. (In Chinese). 
[7] Li L, Wen N, Xia W, Li J, Zhang Y, Liang XF. Analysis on working status of acute flaccid paralysis case surveillance system in China in 2006. Chin J Vac Immun 2007;13(6):518-21. https://kns.cnki.net/kcms2/article/abstract?v=9CXCstbk-tvOV7TjV7QNRLobDqAwQtAS0K9sajxzCfwX6Ne5a2Pm4R6zNi6oWkkyZcnnHODroxaXRtD-trseS-RLZ2c1tKfq6Xbw1oRyfMxqzoJj7E6j3SC6w02yM1-HGpv8J7Hl6HE=&uniplatform=NZKPT&language=CHS. (In Chinese). 
[8] Zhang RZ, Yang JF, Wang XJ, Liu XQ, Zuo SY, Zhang LX, et al. The working status of acute flaccid paralysis case surveillance system in 2000 in China. Chin J Vac Immun 2001;7(6):315-8. https://kns.cnki.net/kcms2/article/abstract?v=9CXCstbk-tsRx_VSNWChCyExOSslHRajvudat7oY-xxkI5pdJQJRH7AlerraCMwBsh_aKIEHy3lFSL9hp5aCvwYmuuApI4fU4QU1VHu_4k7nEG43RmA4VHIqsBE-0dX-pGutb2sWdOQ=&uniplatform=NZKPT&language=CHS. (In Chinese). 
[9] Luo HM, Zhang Y, Wang XQ, Yu WZ, Wen N, Yan DM, et al. Identification and control of a poliomyelitis outbreak in Xinjiang, China. N Engl J Med 2013;369(21):1981 − 90. https://doi.org/10.1056/NEJMoa1303368CrossRef
[10] Yang H, Qi Q, Zhang Y, Wen N, Cao L, Liu Y, et al. Analysis of a Sabin-strain inactivated poliovirus vaccine response to a circulating type 2 vaccine-derived poliovirus event in Sichuan province, China 2019-2021. JAMA Netw Open 2023;6(1):e2249710. https://doi.org/10.1001/jamanetworkopen.2022.49710CrossRef
[11] Wen N, Fan CX, Yan DM, Zhu SL, Wang HB, Liu B, et al. The epidemiology characteristics analysis of vaccine-derived poliovirus and cases in China, 2001-2013. Chin J Vac Immun 2014;20(3):210 − 5. https://doi.org/10.19914/j.cjvi.2014.03.004CrossRef
[12] World Health Orgnization, Global Polio Eradication Initiative, Global Circulating Vaccine‐derived Poliovirus (cVDPV). https://polioeradication.org/wp-content/uploads/2023/11/weekly-polio-analyses-cVDPV-20231107.pdf. [2023-11-7]
[13] Yao N, Liu Y, Xu JW, Wang Q, Yin ZD, Wen N, et al. Detection of a highly divergent type 3 vaccine-derived poliovirus in a child with a severe primary immunodeficiency disorder - Chongqing, China, 2022. MMWR Morb Mortal Wkly Rep 2022;71(36):1148 − 50. https://doi.org/10.15585/mmwr.mm7136a2CrossRef
[14] Wassilak SGF, Williams CL, Murrill CS, Dahl BA, Ohuabunwo C, Tangermann RH. Using acute flaccid paralysis surveillance as a platform for vaccine-preventable disease surveillance. J Infect Dis 2017;216(S1):S293 − 8. https://doi.org/10.1093/infdis/jiw593CrossRef
[15] Wang HQ. Why have cVDPV2 outbreaks increased globally after the polio immunization strategy switch: challenges for the polio eradication endgame. China CDC Wkly 2020;2(11):176 − 9. https://doi.org/10.46234/ccdcw2020.046CrossRef